40 years of service
Oculus director Rainer Kirchhübel celebrates 40th work anniversary
Colin Kerr
Published: Friday, March 1, 2019
Rainer Kirchhübel (left) receiving a certificate in honour of his 40th work anniversary from Andreas Tielmann, Managing Director of the Chamber of Industry and Commerce in Lahn-Dill[/caption]
“You have dedicated your entire working life to OCULUS,” said Co-Director Christian Kirchhübel, at a special ceremony to mark his father’s Rainer Kirchhübel 40th work anniversary.
Rainer Kirchhübel said: “For 38 of my 40 years at OCULUS, I’ve been the Director. These years saw many great challenges, but I always enjoyed it.”
A spokeswoman for Oculus said that from his start at the firm in 1979, engineer Rainer Kirchhübel led the company success as a worldwide high-tech company, and she also pointed out that OCULUS is still a family company. Sons Christian and Matthias are executives at the company, and Rainer’s wife Rita Kirchhübel has been Director of Marketing for over 25 years.
www.oculus.de
Tags: OCULUS
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
ESCRS to Release Guidelines for Cataract and Refractive Surgery
Comprehensive approach to the safest and most effective modern surgery.
Barry Fellowship Opens Up ‘Whole New Field of Thought’
The 2022 recipient combines theoretical and practical to learn new treatments.
Digitalising the OR—Experience and Perspectives
Benefits include saving time and improving outcomes.
Dynamic Measures Needed for Quality of Vision
Functional visual acuity testing and straylight metering may better reflect real-world conditions.
What Is Stopping Digital OR Adoption?
Ophthalmologists know the benefits—now it’s time to construct the right plan.
Time to Move Beyond Monofocal IOLs?
European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.